The PIM family consists of three members, PIM1, PIM2, and PIM3, from which PIM1 and PIM3 have been shown to be upregulated in solid cancers, while PIM2 mostly in hematological cancers [33–36]. Here, PIM1 is linked to hematopoietic and lymphoid cell neoplasm.